STAAR Surgical Company (STAA)
NASDAQ: STAA · Real-Time Price · USD
24.64
+0.55 (2.28%)
At close: Aug 18, 2026, 4:00 PM EDT
24.88
+0.24 (0.97%)
Pre-market: Aug 19, 2026, 7:04 AM EDT
STAAR Surgical Company Revenue
STAAR Surgical Company had revenue of $93.54M in the quarter ending July 3, 2026, with 111.04% growth. This brings the company's revenue in the last twelve months to $339.59M, up 51.30% year-over-year. In the fiscal year ending January 2, 2026, STAAR Surgical Company had annual revenue of $239.44M, down -23.72%.
Revenue (ttm)
$339.59M
Revenue Growth
+51.30%
P/S Ratio
3.64
Revenue / Employee
$368,719
Employees
921
Market Cap
1.24B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jan 2, 2026 | 239.44M | -74.46M | -23.72% |
| Dec 27, 2024 | 313.90M | -8.51M | -2.64% |
| Dec 29, 2023 | 322.42M | 38.02M | 13.37% |
| Dec 30, 2022 | 284.39M | 53.92M | 23.40% |
| Dec 31, 2021 | 230.47M | 67.01M | 41.00% |
| Jan 1, 2021 | 163.46M | 13.28M | 8.84% |
| Jan 3, 2020 | 150.19M | 26.23M | 21.16% |
| Dec 28, 2018 | 123.95M | 33.34M | 36.80% |
| Dec 29, 2017 | 90.61M | 8.18M | 9.92% |
| Dec 30, 2016 | 82.43M | 5.31M | 6.88% |
| Jan 1, 2016 | 77.12M | 2.14M | 2.85% |
| Jan 2, 2015 | 74.99M | 2.77M | 3.84% |
| Jan 3, 2014 | 72.22M | 8.43M | 13.22% |
| Dec 28, 2012 | 63.78M | 1.02M | 1.62% |
| Dec 31, 2011 | 62.77M | 7.81M | 14.21% |
| Dec 31, 2010 | 54.96M | 3.90M | 7.63% |
| Jan 1, 2010 | 51.06M | 1.29M | 2.59% |
| Jan 2, 2009 | 49.77M | -9.59M | -16.16% |
| Dec 28, 2007 | 59.36M | 2.41M | 4.24% |
| Dec 29, 2006 | 56.95M | 5.65M | 11.01% |
| Dec 30, 2005 | 51.30M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| DENTSPLY SIRONA | 3.64B |
| Warby Parker | 911.61M |
| Azenta | 613.81M |
| AtriCure | 569.62M |
| AngioDynamics | 320.17M |
| LeMaitre Vascular | 262.43M |
| BioLife Solutions | 106.69M |
| Kestra Medical Technologies | 95.13M |
STAA News
- 2 days ago - Staar Surgical price target lowered to $28 from $31 at Stifel - TheFly
- 2 days ago - Staar Surgical price target lowered to $19 from $20 at UBS - TheFly
- 6 days ago - STAAR Surgical Company Earnings Call Transcript: Q2 2026 - Transcripts
- 6 days ago - STAAR Surgical Company Earnings release: Q2 2026 - Filings
- 6 days ago - STAAR Surgical Company Quarterly report: Q2 2026 - Filings
- 6 days ago - STAAR Surgical Reports Second Quarter 2026 Results - Business Wire
- 14 days ago - Staar Surgical appoints Warren Foust as president, CEO - TheFly
- 14 days ago - STAAR Surgical Appoints Warren Foust as President and Chief Executive Officer - Business Wire